Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.5225
+0.0110 ( +2.15% ) 9.7K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.5225
Previous close
$0.5115
Volume
9.7K
Market cap
$79.89M
Day range
$0.4960 - $0.5390
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 1 | Oct 06, 2023 |
| 10-k | Annual reports | 97 | Oct 02, 2023 |
| 8-k | 8K-related | 13 | Oct 02, 2023 |
| 8-k | 8K-related | 14 | Sep 29, 2023 |
| nt | Quarterly Reports | 1 | Sep 29, 2023 |
| 4 | Insider transactions | 1 | Sep 12, 2023 |
| 8-k | 8K-related | 13 | Aug 09, 2023 |
| 8-k | 8K-related | 24 | Aug 07, 2023 |
| 8-k | 8K-related | 15 | Aug 07, 2023 |